An Important Gap in Informed Consent Documents for Oncology Clinical Trials-Reference-Cited by-同舟云学术

An Important Gap in Informed Consent Documents for Oncology Clinical Trials

Published:2019-10-01 Issue:10 Volume:5 Page:1399
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Schiffer Charles A.¹

Affiliation:

1. Department of Oncology, Karmanos Cancer Institute, Wayne State University of Medicine, Detroit, Michigan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2748895/jamaoncology_schiffer_2019_vp_190014.pdf

Reference4 articles.

1. Informed consent.;Grady;N Engl J Med,2017

2. Duration of adjuvant chemotherapy for stage III colon cancer.;Grothey;N Engl J Med,2018

3. Patients’ preferences for 3 months versus 6 months of adjuvant chemotherapy (ACT) for colon cancer in the SCOT trial: what survival benefits make longer chemotherapy worthwhile?.;Blinman;J Clin Oncol,2018

4. Food and Drug Administration. International Duration Evaluation of Adjuvant Therapy Informed consent information sheet: guidance for IRBs, clinical investigators, and sponsors. Draft guidance. July 2014. https://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM405006.pdf. Accessed June 17, 2019.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Older Adults with Acute Myeloid Leukemia;Cancer Consult;2023-11-18

2. Improving oncology first-in-human and Window of opportunity informed consent forms through participant feedback;BMC Medical Ethics;2023-02-19

3. An Empirical Study on the Artificial Intelligence-Aided Quantitative Design of Art Images;Wireless Communications and Mobile Computing;2021-10-28

4. Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia;Blood;2021-04-28

5. Future Developments: Innovative Trial Design;Acute Myeloid Leukemia;2021